241 related articles for article (PubMed ID: 25835559)
1. How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.
Moghetti P; Carmina E; De Leo V; Lanzone A; Orio F; Pasquali R; Toscano V
J Endocrinol Invest; 2015 Sep; 38(9):1025-37. PubMed ID: 25835559
[No Abstract] [Full Text] [Related]
2. The polycystic ovary syndrome: a position statement from the Polish Society of Endocrinology, the Polish Society of Gynaecologists and Obstetricians, and the Polish Society of Gynaecological Endocrinology.
Milewicz A; Kudła M; Spaczyński RZ; Dębski R; Męczekalski B; Wielgoś M; Ruchała M; Małecka-Tendera E; Kos-Kudła B; Jędrzejuk D; Zachurzok A
Endokrynol Pol; 2018; 69(4):. PubMed ID: 30209800
[TBL] [Abstract][Full Text] [Related]
3. How to manage an adolescent girl presenting with features of polycystic ovary syndrome (PCOS); an exemplar for adolescent health care in endocrinology.
Mani H; Potdar N; Gleeson H
Clin Endocrinol (Oxf); 2014 Nov; 81(5):652-6. PubMed ID: 24826983
[TBL] [Abstract][Full Text] [Related]
4. [Progress in gynecological endocrinology].
Skałba P
Ginekol Pol; 2008 Dec; 79(12):877-81. PubMed ID: 19175047
[TBL] [Abstract][Full Text] [Related]
5. Reproductive endocrinology: New guidelines for the diagnosis and treatment of PCOS.
Orio F; Palomba S
Nat Rev Endocrinol; 2014 Mar; 10(3):130-2. PubMed ID: 24322653
[TBL] [Abstract][Full Text] [Related]
6. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
[TBL] [Abstract][Full Text] [Related]
7. Optimal management of polycystic ovary syndrome in adolescence.
Hecht Baldauff N; Arslanian S
Arch Dis Child; 2015 Nov; 100(11):1076-83. PubMed ID: 26101431
[TBL] [Abstract][Full Text] [Related]
8. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
Moran LJ; Pasquali R; Teede HJ; Hoeger KM; Norman RJ
Fertil Steril; 2009 Dec; 92(6):1966-82. PubMed ID: 19062007
[TBL] [Abstract][Full Text] [Related]
9. [Highlights of the sixth national gynecological endocrinology summit of the Chinese Medical Association].
Shi YH; Tian QJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):564-6. PubMed ID: 21029608
[No Abstract] [Full Text] [Related]
10. [Ovarian ultrasonographic features in reproductive age females with polycystic ovary syndrome and the establishment of ultrasonographic criteria].
Xie M; Li X; Zhou YQ; Zhao NQ; Lin JF
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2319-22. PubMed ID: 23158559
[TBL] [Abstract][Full Text] [Related]
11. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based approach for the use of ultrasound in the management of polycystic ovary syndrome.
Nardo LG; Gelbaya TA
Minerva Ginecol; 2008 Feb; 60(1):83-9. PubMed ID: 18277355
[TBL] [Abstract][Full Text] [Related]
14. [Polycystic ovary syndrome: PCOS].
Kitaoka Y
Nihon Rinsho; 1997 Nov; 55(11):3012-9. PubMed ID: 9396305
[TBL] [Abstract][Full Text] [Related]
15. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
16. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].
Feichtinger M; Stopp T; Göbl C
Wien Med Wochenschr; 2016 Mar; 166(3-4):139-42. PubMed ID: 26819214
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovarian syndrome in adolescence.
Yii MF; Lim CE; Luo X; Wong WS; Cheng NC; Zhan X
Gynecol Endocrinol; 2009 Oct; 25(10):634-9. PubMed ID: 19533479
[TBL] [Abstract][Full Text] [Related]
19. Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians.
Jeanes YM; Barr S; Smith K; Hart KH
J Hum Nutr Diet; 2009 Dec; 22(6):551-8. PubMed ID: 19735349
[TBL] [Abstract][Full Text] [Related]
20. What does a diagnostic label of 'polycystic ovary syndrome' really mean in adolescence? A review of current practice recommendations.
Morris S; Grover S; Sabin MA
Clin Obes; 2016 Feb; 6(1):1-18. PubMed ID: 26568133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
